{"id":"W4388189854","doi":"10.1016/j.clcc.2023.10.007","title":"Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada","year":2023,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent; Centre Hospitalier Universitaire de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Markham Stouffville Hospital; Southlake Regional Health Center; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Victoria Hospital; Ottawa Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Nova Scotia Health Authority; Centre Intégré de Santé et de Services Sociaux des Laurentides; London Health Sciences Centre; Amgen (Canada); Grand River Hospital","funders":"Amgen","keywords":"Biosimilar; Bevacizumab; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00583274,0.0001857482,0.0005239429,0.0005600749,0.0009266774,0.00112134,0.000651061,0.0004149881,0.0008633569],"category_scores_gemma":[0.01825803,0.0001725721,0.0004897726,0.002018586,0.0007197051,0.0002971763,0.0004887527,0.0006519514,0.00006954618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03009666,"about_ca_system_score_gemma":0.03948204,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8898326,"about_ca_topic_score_gemma":0.9033685,"domain_scores_codex":[0.9956704,0.001158651,0.0002669402,0.000328487,0.002077191,0.0004982873],"domain_scores_gemma":[0.98357,0.002622687,0.006803663,0.0003662565,0.005320382,0.001317019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004678805,0.0002895471,0.9571244,0.0004287582,0.0005731009,0.0001310786,0.0007858255,0.00137396,0.0004899941,0.0003031182,0.002352615,0.03146895],"study_design_scores_gemma":[0.000621047,0.001052898,0.9927396,0.000145663,0.0003089861,0.0001042934,0.0004774565,0.0016027,0.0003616119,0.00008532344,0.002467382,0.00003319329],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990959,0.001770095,0.0002214244,0.001394552,0.00001056001,0.0002226007,0.003100899,0.000008918987,0.002311956],"genre_scores_gemma":[0.9981135,0.0004238801,0.0002130399,0.0002263565,0.000007764426,0.00003838697,0.0008297859,0.000002027866,0.000145221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1101674,"threshold_uncertainty_score":0.2216324,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0337945732910639,"score_gpt":0.3682586052665023,"score_spread":0.3344640319754384,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}